About Seelos Therapeutics, Inc. (SEEL) — Dividend Analysis 2026
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.
Is SEEL a good dividend investment in 2026?
SEEL offers a 540.54% forward yield with a 50% payout ratio. Strand Safety Score: 15/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
SEEL DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your SEEL portfolio grows to $1162696.11M vs $550.5K without reinvestment. This is the compound interest effect in action.
SEEL dividend growth history & forecast
SEEL has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 540.54%.
Company generates negative FCF ($-24M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.0B → -0.1B → -0.1B
15 / 30 pts
15/30
Net income grew in the latest year — positive but trend is unconfirmed
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
15
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 SEEL Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SEEL.
Gross yield
540.54%
Tax rate
15.00%
After-tax yield
459.46%
Real yield (−CPI)
456.66%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
540.54%
537.74%
$54,054 / yr
🇺🇸 US Taxable (15%) ✓
15%
459.46%
456.66%
$45,946 / yr
🇺🇸 US Taxable (20%)
20%
432.43%
429.63%
$43,243 / yr
🇬🇧 UK ISA
0%
540.54%
537.74%
$54,054 / yr
🇬🇧 UK Taxable
8.75%
493.24%
490.44%
$49,324 / yr
🇨🇦 TFSA
0%
540.54%
537.74%
$54,054 / yr
🇨🇦 CA Taxable
25%
405.40%
402.60%
$40,541 / yr
🇦🇺 Super (pension)
15%
459.46%
456.66%
$45,946 / yr
🇦🇺 AU Taxable
30%
378.38%
375.58%
$37,838 / yr
🇩🇪 DE Taxable
26.375%
397.97%
395.17%
$39,797 / yr
🇫🇷 FR Taxable
30%
378.38%
375.58%
$37,838 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SEEL Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your SEEL investment of $0.37/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$300390.50M
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$300390.50M
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in SEEL for:
Shares needed
14,118
Capital required
$5,224
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SEEL Dividend Payment Schedule
SEEL pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 SEEL vs Healthcare Benchmarks
How SEEL compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+537.74% vs sectorBetter
SEEL
540.54%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
SEEL
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
SEEL
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SEEL sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SEEL Insider Activity
No recent SEC filings reported in the last 90 days.
🔬
Financial Health Scores
Altman Z-Score
-156.64
🔴 Distress Zone — elevated dividend cut risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
5/9
⚠️ Moderate fundamentals
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SEEL dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →